← Eichor
Study identifier: NCT05921253 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

Condition: Breast Cancer · Lymphoma  ·  Sponsor: University of Oklahoma

PhaseEARLY_Phase 1
Planned participants104
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

This study is to determine if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain chemical markers of inflammation in study participants' blood.

This description comes directly from the study's public registry record.

Talk to the study team

SCC IIT Office  ·  4052718777  ·  SCC-IIT-Office@ouhsc.edu

Ingrid Block  ·  4052718777  ·  SCC-IIT-Office@ouhsc.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Stephenson Cancer CenterOklahoma City, Oklahoma, United StatesRecruiting
Stephenson Cancer Center- TulsaTulsa, Oklahoma, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05921253